Last $0.49 USD
Change Today -0.0128 / -2.56%
Volume 662.5K
VSCI On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 3:54 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

vision-sciences inc (VSCI) Snapshot

Open
$0.50
Previous Close
$0.50
Day High
$0.55
Day Low
$0.47
52 Week High
03/7/14 - $1.75
52 Week Low
02/18/15 - $0.44
Market Cap
23.5M
Average Volume 10 Days
169.7K
EPS TTM
$-0.15
Shares Outstanding
48.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VISION-SCIENCES INC (VSCI)

Related News

No related news articles were found.

vision-sciences inc (VSCI) Related Businessweek News

No Related Businessweek News Found

vision-sciences inc (VSCI) Details

Vision-Sciences, Inc., through its subsidiaries, designs, develops, manufactures, and markets endoscopy products. It operates through Medical and Industrial segments. The Medical segment designs, manufactures, and sells endoscopy-based products, including flexible fiber and video endoscopes; and EndoSheath disposables. This segment offers cystoscopes to urologists; bronchoscope to intensivists, pulmonologists, thoracic surgeons, and other airway-related physicians; trans-nasal esophagoscopy to general surgeons, primarily bariatric and gastroesophageal reflux disease surgeons, and gastroenterology physicians, as well as ear, nose, and throat (ENT) physicians and others; and ENT endoscopes to ENT physicians and speech pathologists. The Industrial segment designs, manufactures, and sells borescopes products, such as modulars, slim levers, knobs, battery operated portable flexible borescopes, industrial videoscopes, and portable video processors primarily to the aircraft engine manufacturing and aircraft engine maintenance industries. The company distributes its products through direct sales representatives in the United States; and through independent distributors in Europe, Asia, Australia, Canada, the Middle East, Africa, and central and South America. The company was founded in 1987 and is headquartered in Orangeburg, New York.

105 Employees
Last Reported Date: 02/17/15
Founded in 1987

vision-sciences inc (VSCI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $210.9K
Vice President of Disposables Operations
Total Annual Compensation: $170.0K
Vice President of Machida
Total Annual Compensation: $155.0K
Compensation as of Fiscal Year 2014.

vision-sciences inc (VSCI) Key Developments

Vision-Sciences Receives Non-Compliance Notice From NASDAQ

On February 13, 2015, Vision-Sciences, Inc. received a notification letter from the Listing Qualifications Department of The NASDAQ Stock Market (NASDAQ) indicating that, for the last 30 consecutive business days, the Company failed to comply with NASDAQ Marketplace Rule 5550(b)(2), which requires the Company to maintain a minimum Market Value of Listed Securities ("MVLS") of $35 million for continued listing on the NASDAQ Capital Market. The letter also noted that the Company did not meet the alternative requirements under NASDAQ Marketplace Rules 5550(b)(1) or 5550(b)(3). In accordance with NASDAQ Marketplace Rule 5810(c)(3), the Company has 180 calendar days, or until August 12, 2015, to regain compliance with NASDAQ Marketplace Rule 5550(b)(2). To regain compliance, any time before August 12, 2015, the Company's MVLS must close at $35 million or more for a minimum of 10 consecutive business days. NASDAQ's notification letter has no effect on the listing of the Company's common stock at this time. If the Company does not regain compliance with NASDAQ Marketplace Rule 5550(b)(2) prior to the expiration of the compliance period, NASDAQ will provide the Company with written notification that its common stock will be delisted. Upon such notice, the Company may appeal the NASDAQ Staff's determination to a Hearings Panel pursuant to the procedures set forth in the applicable NASDAQ Marketplace Rules. There can be no assurance that, if the Company appeals the NASDAQ Staff's determination, such appeal would be successful. The Company is currently evaluating its alternatives to resolve this listing deficiency. There can be no assurance that the Company will be able to regain compliance with applicable NASDAQ listing requirements.

Vision-Sciences Inc. Presents at BTIG Medical Technology, Diagnostics and Healthcare IT Conference, Feb-18-2015 10:00 AM

Vision-Sciences Inc. Presents at BTIG Medical Technology, Diagnostics and Healthcare IT Conference, Feb-18-2015 10:00 AM. Venue: Cliff Lodge Snowbird Ski &Summer Resort, Snowbird, Utah, United States. Speakers: Howard Zauberman, Chief Executive Officer, President and Director.

Vision-Sciences Receives Non-Compliance Notice From NASDAQ

On February 5, 2015, Vision-Sciences, Inc, received a notification letter from the Listing Qualifications Department of The NASDAQ Stock Market (NASDAQ) indicating that, for the last 30 consecutive business days, the bid price for the Company's common stock has closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under NASDAQ Marketplace Rule 5550(a)(2). In accordance with NASDAQ Marketplace Rule 5810(c)(3), the Company has 180 calendar days, or until August 4, 2015, to regain compliance with the minimum $1.00 price per share requirement. To regain compliance, anytime before August 4, 2015, the bid price of the Company's common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days. NASDAQ's notification letter has no effect on the listing of the Company's common stock at this time. On August 4, 2015, if the Company meets The Nasdaq Capital Market initial listing criteria set forth in NASDAQ Marketplace Rule 5505, except for the minimum bid price requirement, it may be provided with an additional 180 calendar day compliance period to demonstrate compliance. If the Company is not eligible for an additional compliance period at that time, NASDAQ will provide the Company with written notification that its common stock will be delisted. Upon such notice, the Company may appeal the NASDAQ Staff's determination to a Nasdaq Listing Qualifications Panel pursuant to the procedures set forth in the applicable NASDAQ Marketplace Rules. There can be no assurance that, if the Company appeals the NASDAQ Staff's determination, such appeal would be successful. The Company is currently evaluating its alternatives to resolve this listing deficiency. There can be no assurance that the Company will be able to regain compliance with applicable NASDAQ listing requirements.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSCI:US $0.49 USD -0.0128

VSCI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bacterin International Holdings Inc $3.63 USD +0.0401
Cardica Inc $0.63 USD -0.0057
Cytori Therapeutics Inc $1.12 USD 0.00
Stereotaxis Inc $2.39 USD +0.02
Uroplasty Inc $1.21 USD -0.01
View Industry Companies
 

Industry Analysis

VSCI

Industry Average

Valuation VSCI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VISION-SCIENCES INC, please visit www.visionsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.